Innealta Capital’s Axcelis ACLS Stock Holding History

Innealta Capital’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9	Closed	-$1.28K	–	171
2024 Q2	$1.28K	Buy	+9	New	+$1.04K	﹤0.01%	1241

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Innealta Capital's ACLS Position: Q3 2024 in Review

Innealta Capital sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 9 shares — an estimated $1.28K sold.

Innealta Capital first reported a position in ACLS in Q2 2024 and held it in 1 quarter. The position peaked at $1.28K in Q2 2024. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

Innealta Capital reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 9 Axcelis shares in Q3 2024, an estimated $1.28K.
Innealta Capital first reported a position in Axcelis in Q2 2024 and held it in 1 quarter.
Innealta Capital's Axcelis position peaked at $1.28K in Q2 2024.
368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.